RVMD

REVOLUTION MEDICINES INC

Healthcare | Mid Cap

-$1.42

EPS Forecast

$8.68

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
PLXProtalix Biotherapeutics IncVCELVericel CorpRLAYRelay Therapeutics IncBCRXBiocryst Pharmaceuticals IncVIRVir Biotechnology IncRGNXRegenxbio Inc